Mather Group’s Zimmer Biomet ZBH Stock Holding History

Mather Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.6K	Sell	153 -518	-77%	-$49.1K	﹤0.01%	1560
2026 Q2	$57.8K	Sell	671 -84	-11%	-$7.36K	﹤0.01%	1072
2026 Q1	$68.3K	Buy	+755	New	+$69.3K	﹤0.01%	992
2025 Q4	–	Sell	-365	Closed	-$35.9K	–	1674
2025 Q3	$35.9K	Buy	+365	New	+$36.2K	﹤0.01%	985
2025 Q2	–	Sell	-513	Closed	-$58.1K	–	1756
2025 Q1	$58.1K	Sell	513 -148	-22%	-$15.8K	﹤0.01%	870
2024 Q4	$69.8K	Buy	661 +332	+101%	+$35.6K	﹤0.01%	808
2024 Q3	$35.5K	Sell	329 -316	-49%	-$34.5K	﹤0.01%	946
2024 Q2	$85.1K	Buy	645 +56	+10%	+$6.6K	﹤0.01%	854
2024 Q1	$71.7K	Buy	+589	New	+$73.6K	﹤0.01%	794

Other funds holding ZBH

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Wilsey Asset Management San Diego, California $681M AUM 1.1% 1-Year Est. Return

Northside Capital Management Hood River, Oregon $1.25B AUM 16.02% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Gilman Hill Asset Management New Canaan, Connecticut $718M AUM 15.3% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Mather Group's ZBH Position: Q3 2026 in Review

Mather Group reduced its Zimmer Biomet (ZBH) stake by 77% in Q3 2026, selling an estimated $49.1K and leaving 153 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Mather Group first reported a position in ZBH in Q1 2024 and has held it in 9 quarters since. The position peaked at $85.1K in Q2 2024. 151 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

Mather Group held 153 shares of Zimmer Biomet worth $13.6K as of Q3 2026.
Mather Group sold 518 Zimmer Biomet shares in Q3 2026, an estimated $49.1K.
Zimmer Biomet made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1560 holding.
Mather Group first reported a position in Zimmer Biomet in Q1 2024 and has held it in 9 quarters since.
Mather Group's Zimmer Biomet position peaked at $85.1K in Q2 2024.
151 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.